The emergence of precision therapeutics: New challenges and opportunities for Canada's health leaders.
In the era of personalized and precision medicine, the approach to healthcare is quickly changing. Genetic and other molecular information are being increasingly demanded by clinicians and expected by patients for prevention, screening, diagnosis, prognosis, health promotion, and treatment of an increasing number of conditions. As a result of these developments, Canadian health leaders must understand and be prepared to lead the necessary changes associated with these disruptive technologies. This article focuses on precision therapeutics but also provides background on the concepts and terminology related to personalized and precision medicine and explores Canadian health leadership and system issues that may pose barriers to their implementation. The article is intended to inspire, educate, and mobilize Canadian health leaders to initiate dialogue around the transformative changes necessary to ready the healthcare system to realize the benefits of precision therapeutics.
Diagnostic Services Manitoba, Winnipeg, Manitoba, Canada. jslater@dsmanitoba.ca.
Jim
J
Slater
Hoffmann La Roche Limited, Mississauga, Ontario, Canada.
Laura
L
Shields
Canadian College of Health Leaders, Ottawa, Ontario, Canada.
Ray J
RJ
Racette
Alberta Health Services, Edmonton, Alberta, Canada.
Donald
D
Juzwishin
Renown Health, Reno, Nevada, USA.
Max
M
Coppes